A different study of the U251 glioma cell line, however, suggested differently: after CCL2 knockdown, glioma cells exhibited significantly decreased proliferation and migration, and significantly increased apoptotic activity, as compared to control cells (56). This evidence concerns the gene CCL2 and central nervous system cancer.